Project Number 3R44AG053150-07S1 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Development and Commercialization of a Tau Oligomer Inhibitor for AD/RD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator MOE, JAMES G Principal Investigator First Name JAMES Principal Investigator Last Name MOE Awardee Organization OLIGOMERIX, INC Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) FY Overall Cost $160,363 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
